CID 154700101

Irbesartan metabolite 4

Structural Information

Molecular Formula
C25H28N6O2
SMILES
CC(CCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)O
InChI
InChI=1S/C25H28N6O2/c1-17(32)8-13-22-26-25(14-4-5-15-25)24(33)31(22)16-18-9-11-19(12-10-18)20-6-2-3-7-21(20)23-27-29-30-28-23/h2-3,6-7,9-12,17,32H,4-5,8,13-16H2,1H3,(H,27,28,29,30)
InChIKey
YASLDPAAWWZGIP-UHFFFAOYSA-N
Compound name
2-(3-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

444.2274 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 445.23468 204.7
[M+Na]+ 467.21662 216.2
[M+NH4]+ 462.26122 210.2
[M+K]+ 483.19056 214.3
[M-H]- 443.22012 208.2
[M+Na-2H]- 465.20207 212.6
[M]+ 444.22685 207.1
[M]- 444.22795 207.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.